Alannan, M.; Trézéguet, V.; Amoêdo, N.D.; Rossignol, R.; Mahfouf, W.; Rezvani, H.R.; Dittrich-Domergue, F.; Moreau, P.; Lacomme, S.; Gontier, E.;
et al. Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers 2023, 15, 3.
https://doi.org/10.3390/cancers15010003
AMA Style
Alannan M, Trézéguet V, Amoêdo ND, Rossignol R, Mahfouf W, Rezvani HR, Dittrich-Domergue F, Moreau P, Lacomme S, Gontier E,
et al. Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers. 2023; 15(1):3.
https://doi.org/10.3390/cancers15010003
Chicago/Turabian Style
Alannan, Malak, Véronique Trézéguet, Nivea Dias Amoêdo, Rodrigue Rossignol, Walid Mahfouf, Hamid Reza Rezvani, Franziska Dittrich-Domergue, Patrick Moreau, Sabrina Lacomme, Etienne Gontier,
and et al. 2023. "Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer" Cancers 15, no. 1: 3.
https://doi.org/10.3390/cancers15010003
APA Style
Alannan, M., Trézéguet, V., Amoêdo, N. D., Rossignol, R., Mahfouf, W., Rezvani, H. R., Dittrich-Domergue, F., Moreau, P., Lacomme, S., Gontier, E., Grosset, C. F., Badran, B., Fayyad-Kazan, H., & Merched, A. J.
(2023). Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers, 15(1), 3.
https://doi.org/10.3390/cancers15010003